Condition
Prurigo Nodularis clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Prurigo Nodularis clinical trials that are recruiting, at sites in 3 countries (most in China (3), United States (2), Germany (2)). By phase: Phase 3 (2), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 3Countries
Newest Prurigo Nodularis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using nemolizumab (Nemluvio) to treat moderate-to-severe prurigo nodularis in adults | — | Birmingham, Alabama and 50 other locations | Recruiting | May 25, 2025 |
| Evaluating MG-K10 injection for treating prurigo nodularis | Phase 3 | Beijing, Bejing | Recruiting | Jan 16, 2025 |
| Evaluating SHR-1819 injection for treating Prurigo Nodularis in adults | Phase 2/3 | Beijing, Beijing Municipality | Recruiting | Aug 15, 2024 |
| Investigating Dupilumab for Children with Prurigo Nodularis | Phase 3 | Palo Alto, California and 14 other locations | Recruiting | Mar 5, 2024 |
| Understanding the factors influencing chronic inflammatory skin diseases | — | Kiel | Recruiting | Jul 3, 2023 |
| Improving diagnosis and treatment for type 2 inflammatory skin diseases | — | Beijing | Recruiting | Apr 7, 2022 |
All recruiting trials (6)
-
Using nemolizumab (Nemluvio) to treat moderate-to-severe prurigo nodularis in adults
This project tries nemolizumab (Nemluvio) in adults with moderate-to-severe prurigo nodularis to see if it reduces itching and symptoms by six months.
-
Evaluating MG-K10 injection for treating prurigo nodularis
This study is testing a new injection to see if it can help adults with prurigo nodularis feel better by reducing their symptoms.
-
Evaluating SHR-1819 injection for treating Prurigo Nodularis in adults
This study is testing if an injection called SHR-1819 can help adults with Prurigo Nodularis feel better compared to a placebo.
-
Investigating Dupilumab for Children with Prurigo Nodularis
This study is testing if Dupilumab can help children with prurigo nodularis feel better and stay safe while using the medication.
-
Understanding the factors influencing chronic inflammatory skin diseases
This study is trying to understand what causes different types of chronic skin conditions, like eczema and psoriasis, to behave differently in patients over time.
-
Improving diagnosis and treatment for type 2 inflammatory skin diseases
This study is trying to improve how we diagnose and treat type 2 inflammatory skin diseases like atopic dermatitis by creating a specialized center and looking at different treatment methods to see what works best.
Related topics
Quick answers
How many Prurigo Nodularis clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), United States (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.